Nonin Medical, a noninvasive physiological monitoring solutions provider, has received FDA nod for its Model 7600 Regional Oximetry System. It offers real-time monitoring of cerebral oxygenation for patients at risk of ischemia.
The Model 7600 measures oxygen saturation in the cerebral cortex by utilizing Nonin’s EQUANOX regional oximetry (rSO2) technology – next-generation near infrared spectroscopy (NIRS).
The sensor design removes surface tissue effects that can influence measurement accuracy, isolating measurements of the cerebral cortex and providing rSO2 values.
The Model offers signal processing to enhance efficiency and a user interface with Bluetooth wireless connectivity to streamline file access and storage, said the company.